IMCoPharma´s expertise lies in experience and knowledge of the CIS market. The strength of IMCoPharma comes from our ability to work closely with collaboration partners, ultimately maximizing the returns from varied joint ventures.
The company IMCoPharma markets, researches and distributes an extensive range of products manufactured by GMP certified pharmaceutical producer and is bringing the most efficient solutions by offering wider range of global choices.
The company is operating on pharmaceutical market within CIS region where support local pharmaceutical producers but also cooperate with many exclusive business partners worldwide, who provides high quality products.
IMCoPharma represents the whole range of European and world manufacturers of APIs, excipients and FDFs in the markets of CIS countries. Long-term cooperation is mutually beneficial for contractual parties to attain long-term goals. IMCoPharma has become an exclusive and preferred distributor in pharmaceutical industry within CIS region what brings number of advantages for its customers like are reliability and exclusivity in the deal; guaranteed quality of product and services; flexibility and professional attitude; efficiency and prompt delivery. Our goal is delivering market and create outstanding value for you.
In order to fulfil requirements of our customers within CIS territory, the company IMCoPharma constantly expands its services. As a holder of a certificate of registration issued by Ministry of Health of the Czech Republic, IMCoPharma is allowed to handle with and export to the CIS countries narcotic drugs, psychotropic substances and their precursors.
In this regard, IMCoPharma follows Act No. 167/1998 Coll. on Dependency Producing Substances and Art No. 272/2013 Coll. on Drug Precursors issued by Ministry of Health of the Czech Republic.
As these substances can be abused for illicit use, trade between the Community and third countries must be monitored.
The European company IMCoPharma operates a pharmaceutical GDP warehouse in Russia suitable for storage, handling, loading and unloading of palletized goods, labelling and relabelling of goods, repackaging of the goods and distribution of custom cleared the goods to countries of the CIS region and Eurasian Union. The company works exclusively with APIs, excipients, drugs, medical goods including dietary supplements and cosmetics. The warehouse is licensed by Russian Ministry of Health and it complies with Russian and international requirements specified for pharmaceutical warehouse (GDP), temperature controlled, and security limited access.
IMCoPharma takes over the responsibility for sales of the goods to the clients within the CIS region, guarantees payments and insurance of goods supplies.
Contract manufacturing services or supply of goods in bulk are a strategic part of the company and long-term partnerships with clients is one of the major goals. IMCoPharma can provides manufacturing partners with best-in-class sales and product representation. The company has noticed increasing number of companies interested in contract manufacturing services or supply of goods in bulk not only because of numerous benefits it brings (cost savings, benefits for both contractual parties, advanced skilled, significant high quality and innovative products) but also because of IMCoPharma´s good reputation based on customer´s satisfaction. For companies aiming to extend into new markets, the contract manufacturing might be a good option.
The process of transferring pharmaceutical technology into other operation requires many key factors to guarantee its success. IMCoPharma as a reliable and skilled partner offers smooth running of the process for its clients. The success depends on detailed and reliable communication between two parties, past experience and skilled team in project management, discipline and necessary documentation.
IMCoPharma owns several generic dossiers with rights to register, promote and market the products in respective territories but also is able to assist companies to successfully register their dossiers in all indication areas or IMCoPharma knows ensure clients any dossier according to their requirement.
IMCoPharma gives assistance to pharmaceutical companies in defining its in-/out-licensing strategy and maximizing the value of their products and technologies. In and out-licensing activities are excellent opportunities for companies that want to quickly expand their portfolio or obtain an immediate return on investment.
IMCoPharma cooperates with many R&D specialized institutions and continuously stays involved in implementation of results in the practice. The company has successfully executed several co-development projects and initiates a number of end-to-end generic development projects. IMCoPharma is committed to manage the entire project from sourcing/development of APIs to development and validation of formulations to the compilation of registration dossiers, ensuring that all parties execute their tasks thoroughly.
IMCoPharma offers a full range of regulatory expertise ranging from consultation services in connection with product development or in-licensing projects, the provision of regulatory assistance regarding marketing authorization procedures, the compilation of marketing authorization applications for existing products to full product maintenance during the life-cycle of a product. IMCoPharma offers the customers reliable support in handling regulatory and market access challenges related to the products.
The company IMCoPharma provides to its client insurance against insolvency, political risks and macroeconomic problems of the country and insures fixation of the currencies. IMCoPharma is one of the few pharmaceutical companies that offers such an insurance services and many of our clients appreciate it very much. We are a reliable partner and try to understand and satisfy requirements of clients in any way.
Based on many years of experience on pharmaceutical market, IMCoPharma has gradually gained a status of strong and leading business company. Through the years, we have gained valuable knowledge and experience which manifests itself in our flexibility and responsiveness. IMCoPharma is one of the few companies that supports its clients in financing services and provides insurance of delivery in business activities.
Use an opportunity to meet us:
17th – 19th October 2017
18th-19th October 2017
Radisson Blu Belorusskaya
24th - 26th October 2017
Stand no.: 4.0B42
21st – 24th November 2017
Stand no. A107
St. Petersburg, Russia
24th-26th April 2018
9th-11th October 2018